Although ODN1612 did not further reduce obesity or improve diabetes compared to those treated with PBS, ODNR01 further improved type-2 diabetes significantly, including glucose tolerance, insulin sensitivity and serum insulin levels (Fig 6D). This evidence concerns the gene INS and obesity disorder.